Accelerate Diagnostics, Inc. (AXDXQ)
OTCMKTS · Delayed Price · Currency is USD
0.0300
-0.0100 (-25.00%)
May 16, 2025, 4:00 PM EDT

Accelerate Diagnostics Statistics

Total Valuation

AXDXQ has a market cap or net worth of 755,597. The enterprise value is 51.03 million.

Market Cap 755,597
Enterprise Value 51.03M

Important Dates

The last earnings date was Thursday, May 15, 2025.

Earnings Date May 15, 2025
Ex-Dividend Date n/a

Share Statistics

AXDXQ has 25.19 million shares outstanding. The number of shares has increased by 86.76% in one year.

Current Share Class 25.19M
Shares Outstanding 25.19M
Shares Change (YoY) +86.76%
Shares Change (QoQ) +1.17%
Owned by Insiders (%) 38.27%
Owned by Institutions (%) 8.37%
Float 13.66M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 0.06
PB Ratio -0.01
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings -1.02
EV / Sales 4.36
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF -2.07

Financial Position

The company has a current ratio of 0.71

Current Ratio 0.71
Quick Ratio 0.59
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF -2.70
Interest Coverage -2.69

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -73.66%
Return on Invested Capital (ROIC) -147.78%
Return on Capital Employed (ROCE) 1,334.97%
Revenue Per Employee 109,327
Profits Per Employee -467,710
Employee Count 107
Asset Turnover 0.39
Inventory Turnover 2.92

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -96.69% in the last 52 weeks. The beta is 0.22, so AXDXQ's price volatility has been lower than the market average.

Beta (5Y) 0.22
52-Week Price Change -96.69%
50-Day Moving Average 0.66
200-Day Moving Average 1.30
Relative Strength Index (RSI) 12.91
Average Volume (20 Days) 5,474,658

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) 0.17

Income Statement

In the last 12 months, AXDXQ had revenue of 11.70 million and -50.05 million in losses. Loss per share was -2.15.

Revenue 11.70M
Gross Profit 2.70M
Operating Income -35.31M
Pretax Income -50.11M
Net Income -50.05M
EBITDA -31.89M
EBIT -35.31M
Loss Per Share -2.15
Full Income Statement

Balance Sheet

The company has 16.30 million in cash and 66.58 million in debt, giving a net cash position of -50.28 million or -2.00 per share.

Cash & Cash Equivalents 16.30M
Total Debt 66.58M
Net Cash -50.28M
Net Cash Per Share -2.00
Equity (Book Value) -56.04M
Book Value Per Share -2.22
Working Capital -8.96M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -24.19 million and capital expenditures -509,000, giving a free cash flow of -24.70 million.

Operating Cash Flow -24.19M
Capital Expenditures -509,000
Free Cash Flow -24.70M
FCF Per Share -0.98
Full Cash Flow Statement

Margins

Gross Margin 23.12%
Operating Margin -301.85%
Pretax Margin -428.37%
Profit Margin n/a
EBITDA Margin -272.60%
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

AXDXQ does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -86.76%
Shareholder Yield -86.76%
Earnings Yield -6,623.24%
FCF Yield -3,269.34%

Stock Splits

The last stock split was on July 12, 2023. It was a reverse split with a ratio of 0.1.

Last Split Date Jul 12, 2023
Split Type Reverse
Split Ratio 0.1

Scores

AXDXQ has an Altman Z-Score of -39.07. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -39.07
Piotroski F-Score n/a